Ocular Therapeutix
OCUL
#5289
Rank
HK$11.78 B
Marketcap
HK$54.16
Share price
0.73%
Change (1 day)
-3.25%
Change (1 year)

Revenue for Ocular Therapeutix (OCUL)

Revenue in 2024: HK$0.49 Billion

According to Ocular Therapeutix's latest financial reports the company's current revenue (TTM ) is HK$0.43 Billion. In 2024 the company made a revenue of HK$0.49 Billion an increase over the revenue in the year 2023 that were of HK$0.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ocular Therapeutix from 2014 to 2024

Annual revenue

Year Revenue Change
2024HK$0.49 B8.38%
2023HK$0.45 B13.45%
2022HK$0.40 B18.56%
2021HK$0.33 B151.54%
2020HK$0.13 B309.81%
2019HK$32.92 M111.25%
2018HK$15.58 M3.72%
2017HK$15.02 M2.68%
2016HK$14.63 M7.88%
2015HK$13.56 M126.52%
2014HK$5.98 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
SurModics
SRDX
HK$0.94 B 116.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
HK$0.63 B 45.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
HK$0.83 B 91.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
HK$10.37 B 2,280.38%๐Ÿ‡บ๐Ÿ‡ธ USA